- Nasdaq notified Lifeward on March 17, 2026 that it is not in compliance with Listing Rule 5605(c)(2)(A) after Hadar Levy’s resignation reduced the audit committee to two members.
- Nasdaq rules require an audit committee of at least three members, and Lifeward is evaluating options to regain compliance under the cure period in Listing Rule 5605(c)(4).
- The cure period runs until the earlier of the next annual shareholder meeting or February 24, 2027, with an August 24, 2026 deadline if the annual meeting is held before August 24, 2026.
- The notice does not immediately affect trading, and the ordinary shares continue to trade on the Nasdaq Capital Market under the symbol LFWD.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-001574), on March 20, 2026, and is solely responsible for the information contained therein.